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 This paper highlights HIV-related immunosuppression as a major risk factor for influenza 
illness and severity in Malawian adults.  
 Household crowding, food insecurity and poor sanitation are additional risk factors.  
 Influenza preventative strategies should be targeted at HIV-infected adults in Africa. 
 
Short title: HIV and influenza in Malawian adults 
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ABSTRACT 
 
Background. The impact of HIV infection on influenza incidence and severity in adults in sub-Saharan 
Africa is unclear. Seasonal influenza vaccination is recommended for HIV-infected persons in 
developed settings, but is rarely implemented in Africa. 
Methods. We conducted a prospective cohort study to compare the incidence of laboratory-
confirmed influenza illness between HIV-infected and HIV-uninfected adults in Blantyre, Malawi. In a 
parallel case-control study, we explored risk factors for severe influenza presentation of severe 
(hospitalized lower respiratory tract infection (LRTI)), and mild influenza (influenza-like illness (ILI)). 
Results. The cohort study enrolled 608 adults (360 (59%) HIV-infected). Between April 2013 and 
March 2015, 24/229 (10.5%) ILI episodes in HIV-infected and 5/119 (4.2%) in HIV-uninfected adults 
were influenza PCR positive (incidence rates 46.0 vs. 14.5 per 1000 person years, incidence rate ratio 
2.75; 95% confidence interval [CI] 1.02-7.44; p=0.03, adjusted for age, gender, household crowding 
and food security). In the case control study, influenza was identified in 56/518 (10.8%) patients with 
hospitalized LRTI, and 88/642 (13.7%) with ILI. HIV prevalence among influenza-positive cases and 
controls were 69.6% and 29.6% respectively.  HIV was a significant risk factor for severe influenza 
(odds ratio 4.98, 95%CI 2.09-11.88, p<0.001; population attributable fraction 57%, adjusted for 
season, sanitation facility and food security). 
Conclusions. HIV is an important risk factor for influenza-associated ILI and severe presentation in 
this high HIV prevalence African setting. Targeted influenza vaccination of HIV-infected African 
adults should be re-evaluated and the optimal mechanism for vaccine introduction in overstretched 
health systems needs to be determined. 
Keywords: HIV; influenza; Malawi 
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INTRODUCTION 
 
Influenza and its complications are leading causes of morbidity and mortality worldwide [1]. 
Vaccination of patient groups at increased risk of influenza-related complications is key to 
minimizing the impact of disease. Influenza vaccines are currently unavailable in the public sector in 
most sub-Saharan African countries [2]. The World Health Organization (WHO) has therefore called 
for more data on influenza disease burden in the region to guide influenza prevention and control 
programmes [3].  
HIV-infected persons are designated a priority for immunization in many well-resourced countries 
[4, 5], but data to support this recommendation are inconsistent. HIV does not significantly increase 
influenza burden or severity in developed settings [6, 7]. Conversely, in low-resource, high HIV 
prevalence settings there is a higher incidence of influenza illness [8-10], and a greater risk of 
hospitalization [11-13] and death among HIV-infected persons [9, 14, 15]. Current studies however 
are limited by incomplete ascertainment of HIV status, CD4+ cell counts and antiretroviral treatment 
and few have studied the impact of environmental factors, such as household crowding and 
sanitation.  
We therefore aimed to determine the impact of HIV on the frequency and severity of adult 
laboratory-confirmed influenza illness in an urban, high HIV prevalence African setting, and identify 
additional risk factors associated with influenza illness and severity.  
 
METHODS 
 
Study setting and design 
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Malawi is a low-income Southern African country, with an HIV prevalence of 10.6% [16]. Influenza 
predominantly circulates between January and April [17]. There is no national influenza 
immunization program.  
We performed two prospective observational studies at the Queen Elizabeth Central Hospital 
(QECH), the only inpatient facility providing free health care to 1.3 million residents in Blantyre 
district, and a primary care center adjacent to QECH. 
We conducted a cohort study of HIV-infected and HIV-uninfected adults over two years; the primary 
endpoint was laboratory-confirmed influenza illness. We also did a case-control study of adults 
presenting with mild and severe influenza, to establish risk factors for severe influenza (including HIV 
infection). 
 
Procedures 
Cohort study 
We enrolled adults aged >18 years from the antiretroviral treatment (ART), and voluntary 
counselling and testing (VCT) clinics at QECH from April 1, 2013 (eligibility criteria, Figure 1). Active 
follow-up comprised bi-monthly routine clinic reviews. Additionally, participants were instructed to 
attend the study clinic when they developed an influenza-like illness (ILI), defined as reported or 
documented fever (>38C) and >2 of: cough, rhinorrhea, sore throat, myalgia, headache and 
vomiting/diarrhea. The study clinician assessed ill participants and instituted appropriate 
management. Paired nasopharyngeal and oropharyngeal swabs (FLOQswabs, Copan Diagnostics, 
Brescia, Italy) were obtained at routine and ILI visits [18].  
We compared the incidence of laboratory-confirmed influenza-associated ILI between HIV-infected, 
and HIV-uninfected participants. At-risk period was calculated from enrolment to the study end date 
(March 31, 2015), death or loss to follow-up. In cases of the latter, follow-up was censored on the 
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date of relocation, withdrawal of consent, or the last recorded clinic visit. 
Case-control study 
Between May 15, 2013 and Feb 28, 2015, we recruited adults admitted to QECH with acute lower 
respiratory tract infection (LRTI) (severe cases), and adults attending the primary care center with ILI 
(non-severe disease) (eligibility criteria, Figure 2). Nasopharyngeal aspirates were obtained at 
enrolment. Influenza-positive hospitalized LRTI and outpatient-managed ILI formed cases and 
controls respectively.  
Laboratory procedures  
Laboratory testing was performed at the Malawi-Liverpool-Wellcome Trust Clinical Research 
Programme laboratory. HIV status was established by sequential rapid HIV tests (Alere Determine™, 
Japan, and Uni-Gold™, Trinity Biotech, Ireland) [19]. CD4+ cell count was performed on a 
FACScount flow cytometer (Becton Dickinson, BD Biosciences, USA). Nasopharyngeal specimens 
were tested for influenza A and B viruses using the CDC Human Influenza qRT-PCR diagnostic panel, 
and influenza A subtyping kit [20].  
Statistical analysis 
Analysis was performed with Stata 12.1. We tested differences in categorical variables using χ2 or 
Fisher’s exact test, and continuous variables by t-test or Wilcoxon rank-sum test as appropriate.  
The cohort study was powered to detect an incidence rate ratio (IRR) of 3.0 or greater (alpha 0.05, 
two-tailed beta 0.2), for influenza-associated ILI by HIV status requiring 608 recruits allowing for 20% 
loss-to follow-up, based on an estimated cumulative incidence of 40 per 1000 person years in the 
HIV-uninfected cohort and HIV+: HIV- ratio of 60:40. 
Incidence rates of influenza-associated ILI were calculated by dividing the number of events by the 
number of person-years (PYs) follow-up. Poisson regression models estimated IRRs and 95% 
confidence intervals (CI) for the effect of HIV and other risk factors on influenza. Age, sex and HIV 
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were included as potential confounders in the multivariable models. Population average Poisson 
regression models using generalized estimating equations were constructed for recurrent events.  
In both studies, stepwise backwards elimination of covariates with a p-value <0.20 was used to 
rationalize the multivariable models. We limited the number of covariates in a multivariable model 
to maintain events per variable at 10 [21]. Two-way interactions were evaluated in all final models. 
All available case information was used in each univariable analysis. In the multivariable models, we 
excluded patients with missing data for included variables (data were >95% complete for all 
variables). The impact of ART and CD4+ cell count was assessed in subgroup analyses of HIV-infected 
individuals. 
For the case-control study, a sample size of 57 cases and 114 unmatched controls provided 80% 
power to detect an odds ratio (OR) of 2.5 or greater. Based on observed influenza prevalence of 11% 
and 16.4% in adults presenting to QECH with severe and mild acute respiratory illness respectively in 
our sentinel surveillance (Ho et al. unpublished), we estimated recruitment of approximately 518 
adults with hospitalized LRTI and 695 adults with ILI. 
We estimated the OR of having HIV infection and other potential risk factors for severe influenza in 
cases and controls, controlling for confounders, using unconditional logistic regression models. HIV 
and recruitment season were included a priori in the multivariable model.  
Population attributable fractions (PAF) of modifiable risk factors for severe influenza were estimated 
from the prevalence of exposure in cases and adjusted OR from the multivariable logistic regression 
model [22]. 
Ethical approval was provided by the University of Malawi College of Medicine Research Ethics 
Committee, Blantyre, Malawi (P.11/12/1310), and the Research Ethics Committee of the University 
of Liverpool, Liverpool, UK (12.43). 
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RESULTS 
Cohort study - participant characteristics  
In total, 608 adults were enrolled; 360 (59%) had HIV infection (Figure 3 and Table 1). Compared to 
HIV-uninfected participants, HIV-infected participants were older (median age 37 vs. 31 years, 
p<0.001) and a higher proportion were female (69% vs. 55%, p=0.001). Chronic lung disease and 
smoking were uncommon in both groups. A significantly higher proportion of HIV-infected 
participants reported previous tuberculosis (25% vs. 2%, p<0.001) and pneumonia in the past 5 years 
(16% vs. 5%, p<0.001). 
HIV-uninfected participants had larger households, but crowding was similar between the two 
groups. HIV-uninfected participants had better sanitation facilities, water supply and food security. 
No significant differences were observed in education level, employment or asset ownership. 
234 of 360 (65.0%) HIV-infected participants were on ART at enrolment; the majority (82%) for over 
12 months. Median CD4+ cell count at enrolment was 390 cells/µl (interquartile range (IQR) 244-
547).  
Eleven participants died during the study (HIV-infected, n=10); none had reported respiratory 
symptoms prior to death. 61 (10%) participants migrated out of Blantyre, 24 (3.9%) withdrew 
consent, and 25 (4.1%) were lost to follow-up (Figure 3). There was no differential loss-to-follow-up 
by HIV status. Total person-time follow-up were 520 and 348 PYs in the HIV-infected and HIV-
uninfected cohorts respectively. 
The impact of HIV infection on influenza-associated ILI incidence 
We recorded 348 ILI episodes in 208 participants (HIV-infected, n=130) (clinical characteristics, 
Supplementary Table 1). The incidences of ILI presentation were 442 and 341 per 1000 PYs in the 
HIV-infected and HIV-uninfected participants, respectively (IRR 1.21; 95%CI 0.99-1.48). 29 (8.3%) ILI 
episodes were influenza PCR positive (influenza A(H3N2) (n=11), influenza B (n=18)); 24 of 229 
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(10.5%) in HIV-infected participants, and 5 of 119 (4.2%) in HIV-uninfected participants. The 
incidence of laboratory-confirmed influenza-associated ILI in HIV-infected adults per 1000 PYs was 
46.0 (95%CI 30.8-68.6), and 14.5 (95%CI 6.0-34.7) in HIV-uninfected adults (IRR 3.21; 95% CI 1.22-
8.41) (Table 2).  
In the univariable analysis, previous history of pneumonia, household crowding, lower education 
level, unemployment, and food insecurity were associated with influenza-related ILI (Table 2). After 
adjusting for age, gender, household crowding and food security, HIV-infected adults had an 
approximately three-fold increased rate of influenza-associated ILI compared to HIV-uninfected 
adults (adjusted incidence rate ratio (aIRR) 2.75; 95%CI 1.02-7.44; Pearson’s goodness-of-fit test, 
p=0.12).  
Among HIV-infected participants, individuals with enrolment CD4+ count <200 cells/µl had higher 
incidence of influenza-associated ILI than those with CD4 >200 cells/µl, but the association was non-
significant (79.1 vs. 40.5 per 1000 PYs; IRR 1.95; 95%CI 0.78-4.92). The effect of HIV on influenza did 
not differ by ART status. 
Other risk factors for influenza infection 
A household crowding index of 1.5-2.4 was associated with a three-fold increased risk of influenza-
associated ILI, compared to households with <1.5 persons/sleeping room (aIRR 3.41, 95%CI 1.12-
10.36). The increased risk was not observed in participants who lived in household with crowding 
index >2.5 (aIRR 2.06, 95%CI 0.62-6.83) (Table 2). Participants who reported difficulties accessing 
food >2 times/month had a three-fold increased risk of influenza-associated ILI, compared to those 
with no food access difficulties (aIRR 3.09, 95%CI 1.30-7.36). Food insecurity was also a possible 
effect modifier of the impact of HIV on influenza (p=0.01). Among those with frequent difficulty 
obtaining food, HIV was associated with 10-fold increased incidence of influenza-associated ILI (IRR 
9.50, 95%CI 1.27-70.99), but no association was evident in those with little or no food insecurity (IRR 
1.18, 95%CI 0.32-4.39). No interaction was demonstrated with the other covariates. 
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Case-control study – patient characteristics 
1645 patients were assessed for eligibility for hospitalized LRTI and 846 for ILI, with subsequent 
recruitment of 518 and 642 patients, respectively (Figure 4). Patients with severe respiratory 
presentation were older (median age 35 vs. 32 years, p<0.001), predominately male (62% vs. 43%, 
p<0.001), and had a substantially higher prevalence of HIV (77% vs. 30%, p<0.001) (Table 3). They 
also had a higher prevalence of previous pulmonary tuberculosis (18% vs. 7%, p<0.001), pneumonia 
within the past five years (22% vs. 7%, <0.001), smoking (11% vs. 6%, p<0.001) and regular alcohol 
intake (26% vs. 12%, p<0.001). Sanitation facility, water supply, cooking fuel, asset ownership, 
education level, and food security were also worse among patients with hospitalized LRTI.  
Contribution of influenza to mild and severe respiratory infection 
Influenza was identified in 56 (10.8%) patients with hospitalized LRTI (cases) and 88 (13.7%) patients 
with ILI (controls) (Table 4). Influenza A virus was detected in 30 (53.6%) cases and 35 (39.8%) 
controls; all were A(H3N2) except one control (un-subtyped). Two controls were positive for both 
influenza A(H3N2) and B. Influenza A(H1N1)pdm09 was not detected during the study period. 
Risk factors for severe influenza presentation 
Among the 56 cases and 88 controls, no difference in age and sex was observed (Table 4). 39 (69.6%) 
cases and 26 (29.6%) controls were HIV-infected (p<0.001). Compared to HIV-infected controls, HIV-
infected cases had more advanced immunosuppression (median CD4+ count 140 vs. 265 cells/µl, 
p=0.03) and were more likely to be receiving ART (35.7 vs. 9.1%, p<0.001). Cases were more likely to 
have a low body mass index (BMI), report prior history of tuberculosis and pneumonia. Controls had 
better sanitation, education, and food security. However, household exposure to children <5 years 
or crowding did not differ by case-control status.  
In the univariable analysis, HIV, reported history of tuberculosis, pneumonia within past five years, 
low BMI (<18.5 kg/m2), month of recruitment, type of water supply, sanitation facility, lower 
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education level, and food insecurity were associated with being a case (Table 4). Month of 
recruitment was included in the multivariable model a priori due to seasonal discrepancy in the 
recruitment of hospitalized LRTI and ILI patients. In the multivariable model, HIV was strongly 
associated with severe influenza (adjusted OR (aOR) 4.98, 95%CI 2.09-11.88; p<0.001). Additionally, 
reported pneumonia within 5 years (aOR 6.49, 95%CI 2.00-21.07; p<0.001), poor sanitation facility 
(aOR 3.14, 95%CI 1.25-7.84, p=0.01); and frequent difficulty accessing food (aOR 20.85, 95%CI 1.97-
221.16; p=0.01) were independent risk factors for severe influenza.  
In a subgroup analysis of HIV-infected cases and controls, there was a trend towards lower CD4+ 
counts in cases (OR 2.72; 95%CI 0.97-7.60, CD4+ count <200 vs. >200 cells/µl). No association was 
found between ART status and influenza severity. 
Population attributable fraction 
The highest proportions of hospitalized influenza were attributed to HIV (aPAF 56.7%, 95%CI 42.3-
67.4) and poor sanitation (aPAF 40.9%, 95%CI 20.5-56.0) (Table 5). Frequent difficulty accessing food 
accounted for 12% (95%CI 10.6-13.6) of cases.  
DISCUSSION 
In this urban African adult population, HIV is an important risk factor for both symptomatic influenza 
and severe illness. Compared to HIV-uninfected adults, HIV-infected adults had a three times higher 
incidence of influenza-associated ILI, and a five-fold greater odds of severe influenza disease. 
Furthermore, nearly 60% of influenza-related hospitalized LRTI were attributable to HIV.  Although 
neither study was powered to examine the effect of HIV at different levels of immunosuppression, 
our data suggest higher incidence and greater disease severity among those with CD4+ cell count of 
<200 cells/µl.  
Previous population-level surveillance, and retrospective studies in South Africa and Kenya that have 
examined the association between HIV and influenza found a higher disease burden [8-10], and an 
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increased risk of influenza-associated hospitalization in HIV-infected persons [11-13], particular 
among those with severe immunosuppression [13]. The current studies provide robust evidence to 
support these findings having prospectively ascertained HIV status, CD4+ cell count and information 
on ART, as well as other exposures including household and socio-economic characteristics that may 
confound the association between HIV and influenza.  
We found a higher incidence of influenza-associated ILI among HIV-infected, compared to HIV-
uninfected individuals. While this could indicate an increased susceptibility to infection, it may 
instead, or additionally, reflect a greater propensity of HIV-infected individuals to develop 
symptomatic illness following influenza infection, which has been previously described [23]. This is a 
pertinent finding in high HIV prevalence settings, since HIV-infected individuals may play an 
important role in the community transmission of influenza.  
Taken together, data from the two studies present a persuasive argument for a strong association 
between HIV and influenza. The finding that over half of hospitalized influenza presentations in 
Malawian adults were attributable to HIV further emphasizes its critical role in severe influenza in 
this population. Since pneumonia is the commonest cause of adult medical admissions at QECH [24], 
effective influenza preventative strategies could substantially reduce the burden of acute respiratory 
infections in Malawi and other similar resource-limited settings.  
Inactivated influenza vaccines have demonstrated safety and efficacy in HIV-infected persons [25]. 
Clinical efficacy of 75.5% has been reported in South African HIV-infected adults, but the trial 
excluded patients with co-morbidities and ART-naïve patients with CD4+ count <100 cells/l [26]. 
Influenza vaccines are not widely deployed in most African countries [2, 27]. Prior to consideration 
of HIV-infected persons as a target group for immunization, policymakers will require evidence of 
vaccine efficacy in the context of advanced immunosuppression and/or co-morbidities, as well as 
potential public health impact and cost effectiveness of vaccinating HIV-infected individuals, 
compared to other target groups (e.g. pregnant women, young children). Acceptability of annual 
vaccination, feasibility of vaccine administration at ART clinics, and optimal timing of vaccination in 
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the absence of clear seasonality will require elucidation. Numerous regulatory, logistical, and 
financial obstacles will need to be overcome if targeted influenza vaccination policies were to be 
successfully and sustainably implemented in the region. 
The introduction of ART was associated with a dramatic decline in influenza-attributable 
hospitalizations in the US [28], and improved survival following pandemic influenza A(H1N1) 
infection in Mexico [29]. However, this beneficial effect has not been observed in Africa. Cohen et al. 
found no difference in case fatality ratio among HIV-infected individuals with influenza-positive 
severe acute respiratory illness by ART status [30]. A Malawian study demonstrated poor 
reconstitution of influenza-specific CD4+ T-cell response in HIV-infected adults following 12 months 
of HAART, despite a rise in CD4+ count [31]. Hence the impact of ART on the relationship between 
HIV and influenza severity requires further evaluation. 
Identification of household crowding, poor sanitation and food insecurity as risk factors for influenza 
highlight the importance of current public health interventions to alleviate hunger and poverty, and 
improve access to clean water and sanitation [32]. Food insecurity emerged as a previously 
unrecognized risk factor for both influenza illness and severity. More in-depth evaluation of food 
insecurity and its association with influenza and other respiratory infections are warranted [33]. 
Our results, along with other data from the region, contrast with those from developed setting [6]. 
This highlights the limitations of extrapolating findings from developed setting to inform influenza 
control policies in Africa. Differences in observed impact of HIV on influenza burden and severity 
may be due to more advanced immunosuppression, poorer access to ART, higher prevalence of co-
morbid conditions, as well as poverty-related factors identified in this study, compared to other 
regions.  
Our study has several limitations. First, it was conducted in a single urban center, which may limit 
the generalizability of our findings to rural populations. Second, this study was not powered to 
assess the impact of CD4+ count or ART on influenza incidence and severity. CD4+ count was 
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measured during acute illness in the case-control study; the degree of immunosuppression may not 
be accurately represented since CD4+ cell depression can occur during acute illness. Third, passive 
surveillance was used for case ascertainment in both studies; under-ascertainment of ILI episodes, 
and therefore influenza cases are conceivable. Biased estimates away from the null could have 
resulted if HIV-infected cohort participants were more likely to present with ILI compared to 
uninfected individuals. Similar bias could have arisen if HIV-infected individuals had a higher 
propensity to attend hospital with severe respiratory symptoms in the case-control study. However, 
there was no significant difference in ILI incidence between HIV-infected and uninfected cohorts, 
and a greater proportion of HIV-related ILI had severe clinical signs (Supplementary Table 1). 
Furthermore, the majority of case-control study participants were unaware of their HIV status at 
enrolment. Lastly, we were unable to control for bacterial co-infection in the case-control study as 
diagnostic tests for bacteria were undertaken in cases but not controls. 
We have comprehensively evaluated the association between HIV and influenza, identifying HIV-
infected persons at particular risk of symptomatic influenza and severe disease. Influenza 
preventative strategies should be an important aspect of the management of HIV-infected adults in 
sub-Saharan Africa. Further studies are needed in Malawi and other high HIV prevalence settings to 
determine influenza vaccine efficacy in persons with advanced immunosuppression and evaluate 
potential public health impact ahead of operational research to address the logistical barriers to 
implementing large-scale vaccination programs.  
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Table 1. Demographic, clinical, household and socioeconomic characteristics of the cohort 
participants 
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 HIV-infected  HIV-uninfected P for 
difference
a
 
N=360  N=248 
Sex     
Male 113/360 (31)  111/248 (45) 0.001 
Age (years)     
Median (IQR) 37 (31-45)  31 (25-39) <0.001
b
 
Medical history     
Asthma 18/360 (5)  8/248 (3) 0.29 
Chronic lung disease 1/360 (0.3)  0/248 (0) - 
Chronic cardiac disease 2/360 (0.6)  1/248 (0.4) 0.80 
Chronic kidney disease 0/360 (0)  0/248 (0) - 
Chronic liver disease 2/359 (0.6)  0/248 (0) 0.24 
Pregnant (at enrolment) 4/359 (1)  4/248 (2) 0.84 
Previous pulmonary tuberculosis 90/359 (25)  6/248 (2) <0.001 
Pneumonia in past 5 years 59/358 (16)  13//248 (5) <0.001 
Smoking - current 11/360 (3)  4/248 (2) 0.14
c
 
Drinks alcohol 44/359 (12)  35/248 (14) 0.47 
Body mass index <18.5 (kg/m
2
) 38/346 (11)  17/242 (7) 0.18 
Household and socioeconomic factors     
Children <5 years in household (n)     
0 219/358 (61)  132/247 (54)  
1 114/358 (32)  83/247 (33)  
> 2  25/358 (7)  32/247 (13) 0.03 
Individuals >5 years in household (n)     
0-2 89/358 (25)  56/247 (23)  
3-4 161/358 (45)  91/247 (37)  
> 5 108/358 (30)  100/247 (41) 0.03 
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Crowding index
d
     
<1.5 110/360 (30)  66/248 (27)  
1.5-2.4 144/360 (40)  95/248 (38)  
>2.5 106/360 (30)  87/248 (35) 0.33 
Sanitation facility     
None/non-VIP toilet 327/359 (91)  205/248 (83)  
VIP toilet/ flush toilet 32/359 (9)  43/248 (17) 0.002 
Water supply     
River/stream/borehole 75/354 (21)  44/246 (18)  
Public tap/standpipe 212/354 (60)  131/246 (53)  
Piped to dwelling 67/354 (19)  71/246 (29) 0.02 
Principal cooking fuel     
Firewood 77/357 (22)  44/246 (18)  
Charcoal 244/357 (68)  131246 (53)  
Electricity 36/357 (10)  71/246 (29) 0.66 
Highest level of education     
Never attended 18/359 (5)  10/248 (4)  
Primary 152/359 (42)  89/248 (36)  
Secondary/Tertiary 189/359 (53)  149/248 (60) 0.19 
Employment     
Unemployed 87/359 (24)  47/248 (19) 0.13 
Assets owned
e
     
1-2 141/360 (39)  83/248 (33)  
3 151/360 (42)  113/248 (46)  
4-5 68/360 (19)  52/248 (21) 0.36 
Difficulties obtaining food     
Never 137/356 (38)  133/247 (54)  
1-2 times/month 149/356 (42)  86/247 (35)  
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> 2 times/month 70/356 (20)  28/247 (11) <0.001 
Data are n/N (%) unless otherwise indicated. VIP=ventilated improved pit.
  
a
Mantel-Haenszel χ
2
 test unless stated otherwise.  
b
Wilcoxon rank sum test.   
c
Fisher’s exact test.  
d
Total household size/ number of living rooms.  
e
Number of the following assets owned in household: working refrigerator, radio, mobile phone, bed and 
car/motorbike. 
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Table 2.  Risk factors for laboratory-confirmed influenza illness among cohort participants 
Characteristic 
Incidence rate  
per 1000 PYFU 
(95%CI) 
Univariable
a
  Multivariable (model C)
a,b
 
IRR* (95% CI) P-value  IRR* (95% CI) P-value 
Sex       
Male 31.4 (16.9-58.3)  1   1  
Female 34.6 (22.1-54.2) 1.21 (0.52-2.84)  0.66  0.88 (0.40-1.93) 0.74 
Age group (years)       
18-29 20.9 (8.7-50.2)  1   1  
30-39 39.9 (23.2-68.7)  1.73 (0.60-4.97)    1.55 (0.54-4.43)  
 > 40 36.3 (20.1-65.6)  1.33 (0.43-4.05) 0.30  1.42 (0.47-4.28) 0.70 
HIV status       
Negative 14.5 (6.0-34.7)  1   1  
Positive 46.0 (30.8-68.6) 3.21 (1.22-8.41) 0.02  2.75 (1.02-7.44) 0.03 
Medical history       
Previous pulmonary tuberculosis 28.2 (23.3-51.1) 0.82 (0.28-2.43) 0.87    
Pneumonia in past 5 years 54.3 (24.4-120.9) 1.86 (0.75-4.57) 0.14    
Body mass index < 18.5 40.3 (13.0-125.0)  0.81 (0.25-2.68) 0.73    
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Housing characteristics       
Children <5 years in household (n)       
0 36.2 (22.8-57.5)  1     
1 27.8 (13.9-55.6)  0.77 (0.33-1.77)     
> 2  37.3 (12.0-115.5)  1.03 (0.30-3.50) 0.80    
Individuals >5 years in household (n)       
0-2 25.5 (10.6-61.3) 1     
3-4 28.1 (15.1-52.3) 1.10 (0.38-3.22)     
> 5 44.7 (26.5-75.4) 1.76 (0.63-4.87) 0.41    
Crowding index
c
       
<1.5 16.3 (6.12-43.5) 1   1  
1.5-2.4 47.1 (28.8-76.8)  2.88 (0.96-8.62)   3.41 (1.12-10.36)  
 > 2.5 32.0 (16.6-61.5) 1.95 (0.60-6.35) 0.11  2.06 (0.62-6.83) 0.056 
Socio-economic characteristics       
Highest level of education       
Never attended/ Primary 47.6 (30.0-75.6) 1     
Secondary/ Tertiary 22.5 (12.5-40.7) 0.47 (0.22-1.00) 0.05    
Employment       
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No 49.6 (28.8-85.4) 1     
Yes 26.4 (16.2-43.1) 0.53 (0.26-1.11) 0.09    
Food security – difficulty obtaining food       
Never 25.9 (13.9-48.2) 1   1  
1-2 times/month 20.7 (9.9-43.5) 0.80 (0.30-2.10)   0.71 (0.27-1.88)  
> 2 times/month 87.2 (49.5-153.6) 3.35 (1.45-7.76) 0.005  3.09 (1.30-7.36) 0.006 
VIP=ventilated improved pit. 
  
a
IRRs estimated for the incidence of laboratory-confirmed influenza using Poisson regression. 
  
b
Adjusted for sex, age group, HIV status, crowding index and food security.  
c
Total household size/ number of living rooms. 
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Table 3. Demographic, clinical, household and socioeconomic characteristics of adults enrolled 
with hospitalised LRTI and mild ILI  
 
 Hospitalised 
LRTI 
N=518 
ILI 
N=642 
P for 
difference
a
 
Sex    
Male 323/518 (62) 273/642 (43) <0.001 
Age (years)    
Median (IQR) 35 (30-42) 32 (25-43) <0.001
b
 
Pre-hospital/clinic attendance & treatment    
Attended another health facility
c
 312/513 (61) 62/635 (10) <0.001 
Antibiotics within 2 weeks
d
 309/509 (61) 70/630 (11) <0.001 
Antimalarials within 2 weeks 83/511 (16) 13/630 (2) <0.001 
HIV status    
Positive 396/517 (77) 192/640 (30) <0.001 
  CD4+ count (cells/µl) 101 (46-196) 313 (167-450) <0.001
b
 
  On antiretroviral treatment at enrolment
e
 188/233 (81) 68/87 (78) 0.62 
Medical history    
Chronic lung disease 18/503 (4) 15/635 (2) 0.23 
Chronic cardiac disease 2/503 (0.4) 1/635 (0.2) 0.59
f
 
Hypertension 9/503 (2) 19/635 (3) 0.19 
Chronic kidney disease 1/503 (0.2) 0/503 (0) 0.44
f
 
Chronic liver disease 1/503 (0.2) 0/503 (0) 0.44
f
 
Pregnant  2/195 (0) 10/369 (3) 0.19
f
 
Previous pulmonary tuberculosis 90/514 (18) 45/638 (7) <0.001 
Pneumonia in past 5 years 113/512 (22) 46/638 (7) <0.001 
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Body mass index <18.5 (kg/m
2
) 147/495 (30) 67/638 (11) <0.001 
Smoking - current 58/513 (11) 39/638 (6) <0.001 
Drinks alcohol 135/512 (26) 78/638 (12) <0.001 
Household and socioeconomic factors     
Children <5 years in household (n)    
0 296/513 (58) 381/638 (60)  
1 156/513 (30) 195/638 (30)  
> 2  61/513 (12) 62/638 (10) 0.48 
Crowding index     
<1.5 174/497 (35) 219/612 (36)  
1.5-2.4 203/497 (41) 258/612 (42)  
 > 2.5 120/497 (24) 135/612 (22) 0.71 
Sanitation facility    
None/non-VIP toilet 284/514 (55) 260/637 (41)  
VIP toilet 188/514 (37) 252/637 (39)  
Flush toilet 42/514 (8) 125/637 (20) <0.001 
Water supply    
River/stream/borehole 150/514 (29) 134/638 (21)  
Public tap/standpipe 272/514 (53) 308/638 (48)  
Piped to dwelling 92/514 (18) 196/638 (31) <0.001 
Principal cooking fuel    
Firewood 140/514 (27) 129/637 (20)  
Charcoal 325/514 (63) 421/637 (66)  
Electricity  49/514 (10) 87/637 (14) 0.006 
Highest level of education    
Never attended school 49/508 (10) 52/638 (8)  
Primary 274/508 (54) 266/638 (42)  
Secondary / Tertiary 185/508 (36) 320/638 (50) <0.001 
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Employment    
Unemployed 68/514 (13) 91/638 (14) 0.61 
Assets owned
g
    
0 84/515 (16) 75/638 (12)  
1 106/515 (20) 112/638 (18)  
2 122/515 (24) 165/638 (26)  
3 158/515 (31) 206/638 (32)  
4-5 35/515 (9) 80/638 (12) 0.04 
Difficulties obtaining food    
Never 247/514 (48) 367/638 (58)  
1-2 times/month 226/514 (44) 250/638 (39)  
> 2 times/month 41/514 (8) 31/638 (3) <0.001 
Season of recruitment    
Jan-Mar 99/518 (19) 204/642 (32)  
Apr-Jun 100/518 (19) 180/642 (28)  
Jul-Sep 161/518 (31) 145/642 (24)  
Oct-Dec 15/518 (31) 102/642 (16) <0.001 
Data are n/N (%) unless otherwise indicated. VIP=ventilated improved pit latrine.  
a
Mantel-Haenszel χ
2
 test unless stated otherwise.  
b
Wilcoxon rank sum test.  
c 
Included attendance to other hospital, health center, private clinic, traditional healer or pharmacy. 
d
Excluded co-trimoxazole prophylaxis in HIV-infected individuals.  
e
Denominator is the number of patients with known HIV infection at enrolment.  
f
Fisher’s exact test.  
g
Number of the following assets owned in household: working refrigerator, radio, mobile phone, bed 
and car/motorbike. 
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 Table 4. Risk factors for severe influenza presentation in influenza PCR positive cases and controls 
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Characteristic 
Cases
a
  
n=56 
Controls
b
 
n=88 
Univariable
c
  Multivariable
c,d
 
OR (95% CI) P-value  OR (95% CI) P-value 
Sex        
Male 28/56 (50) 43/88 (49) 0.96 (0.49-1.88) 0.89    
Age group (years)        
18-29 17/56 (30) 36/88 (41) 0.75 (0.32-1.73) 0.32    
30-39 22/56 (39) 25/88 (28) 1.40 (0.61-3.22)     
 > 40 17/56 (30) 27/88 (31) 1     
HIV status      1  
Positive 39/56 (70) 26/88 (30) 5.47 (2.63-11.36) <0.001  4.98 (2.09-11.88) <0.001 
Medical history        
Previous pulmonary tuberculosis 10/56 (18) 5/88 (6) 3.61 (1.16-11.20) 0.03    
Pneumonia in past 5 years 17/55 (31) 7/88 (8) 5.18(1.98-13.53) 0.001  6.49 (1.95-21.25) 0.001 
Body mass index <18.5 (kg/m
2
) 12/53 (23) 9/88 (10) 2.57 (1.00-6.60) 0.05    
Housing and socioeconomic characteristics       
Sanitation facility        
None/non-VIP toilet 34/55 (61) 37/88 (42) 2.12 (1.08-4.22) 0.03  3.14 (1.25-7.84) 0.01 
VIP toilet/ flush toilet 22/55 (40) 51/88 (58) 1   1  
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Water supply        
River/stream/borehole 15/56 (27) 19/88 (22) 2.54 (0.93-6.98) 0.07    
Public tap/standpipe 32/56 (57) 40/88 (45) 2.58 (1.07-6.22)     
Piped to dwelling 9/56 (16) 29/88 (33) 1     
Highest level of education        
Never attended 5/55 (9) 15/88 (17) 1     
Primary 34/55 (62) 28/88 (32) 3.64 (1.18-11.27)     
Secondary/ Tertiary 16/55 (29) 45/88 (51) 1.07 (0.33-3.41) 0.002    
Difficulties obtaining food        
Never 28/56 (50) 58/88 (66) 1   1  
1-2 times/month 21/56 (38) 29/88 (33) 1.50 (0.73-3.08)   1.15 (0.47-2.84)  
> 2 times/month 7/56 (12) 1/88 (1) 14.4 (1.70-123.65) 0.007  20.85 (1.97-221.16) 0.01 
Month of recruitment        
Jan-Mar 16/56 (29) 49/88 (56) 1   1  
Apr-Jun 15/56 (27) 18/88 (20) 2.55 (1.05-5.20)   3.36 (1.13-9.95)  
Jul-Sep 12/56 (21) 9/88 (10) 4.08 (1.45-11.46)   6.34 (1.69-23.80)  
Oct-Dec 13/56 (23) 12/88 (14) 3.32 (1.25-8.72) 0.01  3.60 (1.07-12.10) 0.01 
Data are n/N (%). 
VIP=ventilated improved pit latrine.
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a
Influenza-PCR positive hospitalised lower respiratory tract infection.
  
b
Influenza-PCR positive influenza-like illness.  
c
Unconditional logistic regression.  
d
Adjusted for HIV status, history of pneumonia within 5 years, month of recruitment, sanitation facility, and food security. 
Downloaded from https://academic.oup.com/cid/article-abstract/doi/10.1093/cid/cix903/4554430
by guest
on 13 November 2017
  33 
Table 5.  Population attributable fraction of modifiable risk factors for severe influenza 
 
 
  
 % exposed 
among 
cases 
Adjusted OR 
(95% CI) 
p-value Adjusted PAF  
(95%CI) 
HIV infection 70 4.98 (2.09-11.88) <0.001 56.7% (42.3-67.4) 
Sanitation facility     
None/non-VIP toilet  39 3.14 (1.25-7.84) 0.01 40.9% (20.5-56.0) 
VIP/ flush toilet 61 1   
Difficulties obtaining food     
Never 50 1  - 
1-2 times/week 38 1.15 (0.47-2.84)  6% (-40.9-38.0) 
> 2 time/ week 12 20.85 (1.97-221.16) 0.01 12.0% (10.3-13.7) 
VIP=ventilated improved pit latrine. 
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Figure legends 
 
Figure 1. Eligibility criteria for cohort study 
Figure 2. Eligibility criteria for case control study 
Figure 3. Recruitment and progress of cohort participants 
Flow diagram for recruitment, loss to follow-up and influenza-like illness events among cohort 
participants.  
a
Reasons for ineligibility: intention to relocate out of Blantyre (n=10); unable to attend regular study 
visits (n=6); unable to give written informed consent (n=1); evidence of active acute respiratory 
disease at enrolment (n=17); and another household member enrolled in study (n=2). 
bReasons for declining consent: no time (n=3); not interested (n=2); fear of participation (n=4); and, 
wished to seek spouse's consent (n=2). 
Figure 4. Case control study recruitment 
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Figure 1. 
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Figure 2. 
 
 
  
Downloaded from https://academic.oup.com/cid/article-abstract/doi/10.1093/cid/cix903/4554430
by guest
on 13 November 2017
  37 
Figure 3. 
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Figure 4. 
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